James Noble
CIK 1388000 · Chief Executive Officer · last filed 2025-11-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$386.64M
Companies
6
Total Filings
28
Lifetime Open-Market Net
-$7.27M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LAVA Therapeutics NV (LVTX) Delisted | Director | — | $1.74 | — | $0 | 2 | 2025-11-17 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | 0 | $0.06 | $0 | -$6.07M | 7 | 2022-07-01 |
| GW PHARMACEUTICALS PLC (GWPH) Delisted | Director | 41,300 | $218.96 | $9.04M | -$1.27M | 4 | 2021-02-24 |
| ASND | Chief Executive Officer | 1,773,100 | $218.06 | $386.64M | $0 | 4 | 2019-05-17 |
| STRATA Skin Sciences, Inc. (MELA) Delisted | Director | — | — | — | $0 | 1 | 2012-01-06 |
| CURAGEN CORP (CRGN) Delisted | Director | 20,000 | — | — | $57.4K | 7 | 2009-05-14 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-01-15 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Sell (S) | −300,000 | -$1.40M | EDGAR |
| 2019-05-29 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Mixed | — | -$933.7K | EDGAR |
| 2019-05-17 | ASND | Exer (M) | +1,773,100 | $253.6K | EDGAR |
| 2019-03-05 | GW PHARMACEUTICALS PLC (GWPH) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-08 | ASND | Grant (A) | — | $0 | EDGAR |
| 2018-01-17 | ASND | Grant (A) | — | $0 | EDGAR |
| 2017-01-18 | ASND | Grant (A) | — | $0 | EDGAR |
| 2016-01-20 | Adaptimmune Therapeutics PLC (ADAP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2012-01-06 | STRATA Skin Sciences, Inc. (MELA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-10-06 | — | Disp (D) | −20,000 | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.